
Unlike invasive zzso the prognosis and outcome of zzso zzso patients who develop invasive zzso have not significantly improved over the past decade as a majority of patients who develop the infection still die 12 weeks after zzso However, early recognition and treatment of invasive zzso zzso as well as individualized approaches to treatment and secondary zzso could improve the odds of survival, even in the most persistently zzso patient receiving chemotherapy and/or of stem cell zzso zzso we describe the subtle clinical and zzso clues that should alert the zzso to the possibility of zzso and aggressive and timely treatment approaches that may limit the spread of infection before it becomes zzso zzso patients with this opportunistic infection require integrated care across several disciplines and frequently highly individualized and complex sequence of zzso We also offer perspectives for the use of 2 zzso zzso B products and zzso with activity against zzso The availability of zzso in an oral zzso that can be administered safely for prolonged periods makes it an attractive agent for long-term primary and secondary zzso However, serum drug concentration monitoring may be required to minimize breakthrough infection or zzso zzso associated with inadequate blood zzso 

